Ocugen (OCGN) Notes Payables (2018 - 2021)

Ocugen (OCGN) reported Notes Payables of $374000.0 for Q1 2021, up 59.83% quarter-over-quarter from $234000.0 in Q4 2020.

Ocugen (OCGN) Notes Payables (2018 - 2021) Analysis & Trends

Ocugen has reported Notes Payables for 4 years, with the latest figure at $374000.0 in Q1 2021.

  • For the quarter ending Q1 2021, Notes Payables changed N/A year-over-year to $374000.0; the trailing twelve-month figure through Mar 2021 stood at $374000.0 (changed N/A YoY), and the FY2020 full-year result was $234000.0, changed N/A from the prior year.
  • Notes Payables for Q1 2021 stood at $374000.0, up from $234000.0 in the prior quarter.
  • The five-year high for Notes Payables was $7.5 million in Q4 2018, with the low at $234000.0 in Q4 2020.
  • Historically, Notes Payables has averaged $3.0 million across 4 years, with a median of $2.6 million in 2020.
  • The largest YoY upside for Notes Payables was 6.94% in 2020 against a maximum downside of 6.94% in 2020.
  • Ocugen's Notes Payables stood at $7.5 million in 2018, then slumped by 41.59% to $4.4 million in 2019, then slumped by 94.65% to $234000.0 in 2020, then surged by 59.83% to $374000.0 in 2021.
  • The last three Notes Payables figures came in at $374000.0 (Q1 2021), $234000.0 (Q4 2020), and $1.2 million (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ocugen 411.07 Mn 411.07 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 374,000.00
Dec 31, 2020 234,000.00
Sep 30, 2020 1.21 Mn
Jun 30, 2020 4.07 Mn
Jun 30, 2019 4.37 Mn
Dec 31, 2018 7.48 Mn